In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

American Reagent Inc.

Division of Daiichi Sankyo Co. Ltd.
www.americanreagent.com

Latest From American Reagent Inc.

More US Positions Go As Daiichi Sankyo Refocuses

Attempts to maximize the current commercial portfolio and prepare for upcoming pipeline launches spell more job losses at the US arm of major Japanese pharma Daiichi Sankyo.

United States Commercial

Roxadustat To Overtake Epogen In Treating Anemia In CKD By 2021

The market for the treatment of anemia in chronic kidney disease will see Epogen eroded by biosimilars before the overall segment finally returns to growth following the launch of HIF-PHI inhibitor roxadustat, according to Datamonitor Healthcare's latest forecast.

Renal Market Intelligence

Roxadustat To Overtake Epogen In Treating Anemia In CKD By 2021

The market for the treatment of anemia in chronic kidney disease will see Epogen eroded by biosimilars before the overall segment finally returns to growth following the launch of HIF-PHI inhibitor roxadustat, according to Datamonitor Healthcare's latest forecast.

Renal Market Intelligence

Code Cart Crisis: Anatomy Of An Emergency Drug Shortage

How FDA, health care providers, and Pfizer and other drug makers are responding to a shortage of emergency medicines from the fragile, overstressed US sterile injectables sector.

Manufacturing Quality
See All

Company Information

  • Industry
  • Medical Devices
    • Biomaterials
  • Pharmaceuticals
    • Drug Delivery
      • Nasal
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Luitpold Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Daiichi Sankyo Co. Ltd.
  • Senior Management
  • Ken Keller, Pres. & CEO
    Joseph J Boyle, VP, CFO
    Gopal Anyarambhatla, PhD, VP, R&D
    Linda M Mundy, MD, PhD, CMO
  • Contact Info
  • American Reagent Inc.
    Phone: (631) 924-4000
    5 Ramsey Rd.
    Shirley, NY 11967
    USA
UsernamePublicRestriction

Register